You are here : Home / All Sectors / Healthcare / Biotechnology / BIOCON LTD

BIOCON Analysis

Returns | 1W : 7.6% , 1M : 21.1%,1Y : 99.8%

BSE : 532523 NSE : BIOCON

LT :

Long Term Analysis

Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Average

The long term FVD (Fundamentals - Valuation - Debt) Squares represent long term view for a company based on Annual Earnings, Valuation and Debt of the stock. This summary is suitable for Investors investing in the market with a time horizon of more than 3 years.

Good
Average
Bad

Updated:

ST :

Short Term Analysis

Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%

The short term QPP (Quarterly Earnings Trend- Price Momentum - Pledged Shares) Squares represent short term view for a company which is suitable for Traders taking positions in the market with a time horizon of less than 3 years .

Good
Average
Bad

Sep 29,2020

Price(EOD): Rs. 455.85

This is the End-of-Day (EOD) Stock Price updated daily by 10 pm IST.

Industry : Biotechnology

MarketCap: Rs. 54,702.00 Cr

Latest Annual Report(BSE)

Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns	1W	1M	1Y
BIOCON	7.6%	21.1%	99.8%
PANACEA BIOTEC	3.6%	4%	32.9%

FUNDAMENTAL ANALYSIS OF BIOCON

Fundamental Score of the company compares the financial strength of the company with it's Industry peers as well as other companies in the stock market.

Fundamental Score is derived based on the statistical analysis of 10+ years historical data for consistency, drift and industry outperformance of underlying attributes listed below:

1. Company size based on Revenues. Learn More
2. Growth based on Net Income . Learn More
3. Profit Margins. Learn More
4. Return on Capital Employed (ROCE). Learn More
5. Debt Ratios. Learn More
6. Return on Invested Capital (ROIC). Learn More
7. Cost of Capital (WACC). Learn More
8. Moat size. Learn More

Please check the Financials tab for more information.

Fundamentals Score

[Last Annual Data : Mar2020 | TTM

Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More

]

Show Me the Stocks with Fundamentals better than BIOCON ^Premium

Is BIOCON good for long term investment?

As on 29-Sep-2020, the Fundamentals of BIOCON are Strong and hence it's good for long term investment! See Financial Performance of BIOCON . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

VALUATION OF BIOCON

Valuation Score of the company compares the current market value with the intrinsic/fair value of the business as compared to other companies. The fair value has been calculated based on three models:

1. Median Enterprise Value to EBIDTA model calculated over last 12 years data (where available).
Enterprise Value = Market Cap + Debt - Cash. Learn More

2. Median Enterprise Value to Sales model calculated over last 12 years data (where available).
Enterprise Value = Market Cap + Debt - Cash. Learn More

3. Median Price to Sales model calculated over last 12 years data (where available). This model is useful to analyze no profit companies. Learn More

Valuation Score

Ratio	Value
P/E P/B P/S PEG	158.37 10.97 26.97 -

Show Me the Stocks with Valuation better than BIOCON ^Premium

Is BIOCON UnderValued or OverValued?

As on 29-Sep-2020, BIOCON is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

INTRINSIC VALUE OF BIOCON

This section compares the current market price of the stock with Intrinsic value of the stock calculated based on 3 Valuation models described in the Valuation section.

If Intrinsic Value (Enterprise Value/EBIDTA Model) is -ve, the company made a loss in last financial year or had a high debt.

If Intrinsic Value (Enterprise Value/Sales Model) is -ve, the company had a high debt in the last financial year.

If Intrinsic Value (EV/Sales OR Price/Sales Model) is 0, the latest data is not available.

Model	Discount(-)/ Premium(+)
EV/EBIDTA EV/Sales Price/Sales	746% 411% 433%

What is the Intrinsic Value of BIOCON ?

As on 29-Sep-2020, the Intrinsic Value of BIOCON is Rs. 85.45 determined based on Median of the 3 historical models.
Intrinsic Value based on Median EV / EBIDTA Model : Rs. 53.88
Intrinsic Value based on Median EV / Sales Model : Rs. 89.21
Intrinsic Value based on Median Price / Sales Model : Rs. 85.45
Median Intrinsic Value of BIOCON : Rs. 85.45

Is BIOCON trading at a Premium or Discount?

As on 29-Sep-2020, BIOCON is trading at a Premium of 433% based on the Median Intrinsic Value!

SHARE PRICE MOMENTUM OF BIOCON

| 10 Year Share Price Graph

DEBT

Year	Debt/Equity ratio
Debt/Equity ratio analysis For Banking industry, Good = Ratio less than 13 Average = Ratio between 13 and 15 Bad = Ratio greater than 15 For all non-Banking industries, Good = Ratio less than 0.4 Average = Ratio between 0.4 and 0.6 Bad = Ratio greater than 0.6 Worst is considered between Standalone & Consolidated	Standalone	Consolidated
2020 2019 2018 Avg_3yrs	0 0.01 0.02 0.01	0.4 0.4 0.44 0.41
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares	0 %
As of : July 14,2020
If less than 25%	Good
If between 25% and 50%	Neutral
If greater than 50%	Bad

QTRLY RESULTS

Parameter	1 Qtr Growth	4 Qtr Growth
Revenue Op Profit EBIDT Net Income	7.94% 38.07% 16.96% -9.4%	8.3% 54.71% -18.76% -30.49%
QtrlyTrend	2 Quarterly Trend analysis The growth rate score are assigned as under: If ratio's 1Q growth is +ve, then 1. If -ve, then -1. If ratio's 4Q growth is +ve, then 1.If -ve, then -1. Growth Score= Sum of all the above scores for Revenue, Operating Profit and Net Income. Interpretation Good = Growth Score >=4 Neutral = Growth Score between 0 and 4 Bad = Growth Score less than 0
Latest Qtr: Jun2020